Sunday 5th February, 2012   |   Welcome, guest. Please, login or register  
Monday October 19, 15:01

Nanotechnology to fight cancer

Fluorescent properties of quantum dots (color emitted depends on the particle size) aimed to detect the cancer
Fluorescent properties of quantum dots (color emitted depends on the particle size) aimed to detect the cancer
 

Fluorescent markers help the surgeon to identify in real time the contours of the malignant tumor. Such "smart" drugs can be activated remotely when they reach their target.

Like other fields of medicine, cancer begins the era of nanotechnology. Most of the tiny nanotools, sized a billionth ("nano" in Greek) of a meter, are still at the research stage. But they open exciting opportunities for both cancer diagnose and treatment.

As for diagnostics, a major challenge is to develop nanoprobes capable of binding to cancer cells. Injected into the body, they may reveal the presence of a tumor by emitting a signal, radioactive or optical for example.

Scientists say that the ideal tracer, which marks 100% cancer cells, is probably a myth. Researchers are working on two promising approaches one of which, the nanoemulsion of fluorophore, that can illuminate the lymphatic system.

This tracer when testing in animals, identified the pathways by which cancer cells are scattered in the patient's body. By protecting the fluorophore, the nanoemulsion yields a very high brightness and high stability, which can help to  apply this technique to many types of cancer.

There are also a marker of angiogenesis, i.e. formation of new blood vessels that accompanies the growth of cancerous tumors. Coupled to the optical system it will help the surgeon to directly visualize the potentially cancerous cells and the limits of the tumor during surgery.

Currently under study in small animals, this marker will nevertheless go through the same workflow as a drug. Early clinical trials are planned around 2011.

 
Rate:
  •  
Please, login to rate the article.
 
 

Recommended articles:

 

Lung Cancer: A successful transplantation of an artificial bronchus

If the tumor is located in the periphery of the lung, only a portion of the lung is removed. But if the tumor is more central, complete removal may be necessary
The team of Professor Emmanuel Martinod successfully transplanted artificial bronchus in a78 year patient with cancer, saving him the complete removal of the lung.
 

On the trail of a vaccine against brain cancer

EGFRVIII marker is also found in other cancers (like breast or lung) but not in normal tissues
A therapeutic vaccine, tested in combination with conventional therapy in twenty patients, has extended survival by about 70%. These preliminary results have been obtained by the team of John Sampson at Duke University (United States).
 

Discovery of a key gene involved in breast cancer

An abnormal NRG1 gene involved in half of breast cancers, and probably many other malignancies, such as colon, prostate, ovary or bladder.
Abnormal NRG1 gene is responsible for breast cancer, and probably many other malignancies, such as colon, prostate, ovary or bladder.
 

Most recent in the category Cancer:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

Please, login to post comments.
 
 
 
 

Home | Social Health | AIDS | Cancer | Deseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2012 Heal-all.org. All rights reserved.